Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials-Reference-Cited by-同舟云学术

Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials

Published:2021-04 Issue:2 Volume:19 Page:e92-e99
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Marconi Lorenzo,Sun Maxine,Beisland Christian,Klatte Tobias,Ljungberg Boerje^ORCID,Stewart Grant D.^ORCID,Dabestani Saeed^ORCID,Choueiri Toni K.,Bex Axel

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference15 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study;Dabestani;World J Urol,2016

3. Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial;Gross-Goupil;Ann Oncol,2018

4. Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma;Motzer;J Clin Oncol,2017

5. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy;Ravaud;N Engl J Med,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort;BJUI Compass;2024-06-10

2. HSP27 promotes vasculogenic mimicry formation in human salivary adenoid cystic carcinoma via the AKT-MMP-2/9 pathway;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-05

3. Sarcoid-like reaction and hypothyroidism induced by PD-1 inhibitor treatment in metastatic renal cell carcinoma: a case report and literature review;BMC Pulmonary Medicine;2024-03-08

4. Prognostic Value of the Lung Immune Prognostic Index on Recurrence after Radical Surgery for High-Risk Renal Cell Carcinoma;Cancers;2024-02-14

5. Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the “TOWARDS” Score;Annals of Surgical Oncology;2024-01-29